Here is the latest stock price and chart of AJANTA PHARMA. For more details, see the AJANTA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Know More: Which way are the markets & the mutual fund industry headed?
Live BSE Quotes | Jan 25, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,748.05 | Open (Rs) 1,710.00 | High (Rs) 1,792.45 | Low (Rs) 1,698.75 |
% Change1.55 | Volume 11,241 | Value (Rs) 19,807,520 | 52-Week H/L 1,844.10 / 961.65 |
Live NSE Quotes | Jan 25, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,758.95 | Open (Rs) 1,730.10 | High (Rs) 1,794.40 | Low (Rs) 1,700.00 |
% Change2.20 | Volume 137,055 | Value (Rs) 241,072,892 | 52-Week H/L 1,844.90 / 961.00 |
Change | |||||
---|---|---|---|---|---|
1 Day 1.55% | 1 Month 3.63% | 3 Months 10.89% | 1 Year 49.07% | 5 Years (CAGR)* 7.49% | 10 Years (CAGR)* 51.29% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 63.07 | P/E Ratio (x) 27.72 | Market Cap (Rs m) 153,741.00 | P/BV (x) 6.85 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
AJANTA PHARMA last traded price was up 1.6% to Rs 1,748.1 on the BSE. On the NSE, AJANTA PHARMA last traded price was up 2.2% to Rs 1,759.0. The total volume of shares traded was 0.1 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.9%. And the benchmark S&P BSE SENSEX was at 48,347.6 (down 1.1%).
Over the last 30 days, the AJANTA PHARMA share price is up 6.3%. And over the last one year, AJANTA PHARMA share price is up 46.7%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.
For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.
For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.
Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.
Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.
More